(Q42546605)

2 November 2017

title

Efficacy of immunization of high-risk infants against hepatitis B virus evaluated by polymerase chain reaction (English)

1 reference

2 November 2017

0 references

1 reference

Matsumoto T

1

1 reference

2 November 2017

Nakata K

2

1 reference

2 November 2017

Hamasaki K

3

1 reference

2 November 2017

Daikokoku M

4

1 reference

2 November 2017

Nakao K

5

1 reference

2 November 2017

Yamashita Y

6

1 reference

2 November 2017

Shirahama S

7

1 reference

2 November 2017

Kato Y

8

1 reference

2 November 2017

publication date

1 November 1997

1 reference

Journal of Medical Virology

2 November 2017

published in

1 reference

2 November 2017

volume

53

1 reference

2 November 2017

issue

3

1 reference

2 November 2017

page(s)

255-260

1 reference

describes a project that uses

2 November 2017

polymerase chain reaction

1 reference

based on heuristic

inferred from title

cites work

Hepatitis B virus. The major etiology of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Vaccine-induced escape mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Fulminant reactivation of hepatitis B due to envelope protein mutant that escaped detection by monoclonal HBsAg ELISA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

National project on the prevention of mother-to-infant infection by hepatitis B virus in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Gly145 to Arg substitution in HBs antigen of immune escape mutant of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Prevalence of hepatitis B or C virus infection in patients with fulminant viral hepatitis. An analysis using polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

A novel hepatitis B virus variant in the sera of immunized children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

A molecular analysis of viral persistence in surface antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Long-term follow-up of hepatitis B vaccine in infants of carrier mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Changes in HBsAg carrier rate in Goto Islands, Nagasaki Prefecture, Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Enhanced immunogenicity of the pre-S region of hepatitis B surface antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Mutations within the S gene of hepatitis B virus transmitted from mothers to babies immunized with hepatitis B immune globulin and vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Molecular epidemiology of hepatitis B virus vaccine variants in Singapore

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Detection of hepatitis B virus in serum using amplification of viral DNA by means of the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Hepatitis B virus DNA in serum and liver is commonly found in chinese patients with chronic liver disease despite the presence of antibodies to HBsAg

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Mutations in S region of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Glycine-to-arginine substitution at codon 145 of HBsAg in two infants born to hepatitis B e antigen-positive carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Natural history of hepatitis B surface antigen mutants in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Immunogenicity and safety in newborns of a new recombinant hepatitis B vaccine containing the S and pre-S2 antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis-B vaccine and hepatitis-B immunoglobulin. Double-blind randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

Risk factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-9071%28199711%2953%3A3%3C255%3A%3AAID-JMV13%3E3.0.CO%3B2-G

10.1002/(SICI)1096-9071(199711)53:3<255::AID-JMV13>3.0.CO;2-G

21 January 2018

Identifiers

DOI

1 reference

2 November 2017

1 reference